Home › Funds › Siren, L.L.C. › TNGX
Siren, L.L.C. position in TNGX
Tango Therapeutics, Inc. · Health Care
Siren, L.L.C. reported holding 6,784,081 shares of TNGX (Tango Therapeutics, Inc.) in its Q3 2026 13F filing — a position valued at US$169.3M, representing 4.02% of its reported portfolio and ranking #6 among its reported holdings. Siren, L.L.C. has disclosed TNGX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Siren, L.L.C.'s TNGX position evolved
Siren, L.L.C. first disclosed a stake in TNGX in Q3 2024 at 2,603,897 shares (US$20.1M). The position peaked in Q2 2026 at 6,179,364 shares, worth US$193.2M. Across 9 filings, Siren, L.L.C. increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 6,784,081 shares valued at US$169.3M — an increase of 604,717 shares quarter over quarter.. Notable position changes include a 31% increase in Q2 2025 (shares rose 64% over the following quarter), a 75% increase in Q3 2025 (shares rose 5% over the following quarter), a 39% increase in Q4 2025 (shares rose 136% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 2.60M | $20.05M | New |
| Q4 2024 | 2.60M | $8.05M | Hold |
| Q1 2025 | 2.57M | $3.51M | Reduce |
| Q2 2025 | 3.36M | $17.23M | Add |
| Q3 2025 | 5.88M | $49.42M | Add |
| Q4 2025 | 8.17M | $72.35M | Add |
| Q1 2026 | 5.66M | $118.35M | Reduce |
| Q2 2026 | 6.18M | $193.17M | Add |
| Q3 2026 | 6.78M | $169.26M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TNGX and 13F data
TNGX (Tango Therapeutics, Inc.) is a Health Care company. 84 other funds we track also report a position in TNGX — the largest reported positions include RTW INVESTMENTS, LP (US$434.5M), Farallon Capital Management (US$383.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$383.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TNGX
- RTW INVESTMENTS, LP 13.90M sh · $434.53M · Q2 2026
- Farallon Capital Management 12.28M sh · $383.78M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 12.28M sh · $383.78M · Q2 2026
- Boxer Capital Management, LLC 10.88M sh · $339.99M · Q2 2026
- TCG Crossover Management, LLC 9.08M sh · $283.88M · Q2 2026
- Paradigm Biocapital Advisors LP 6.36M sh · $198.74M · Q2 2026
- Deep Track Capital, LP 4.20M sh · $131.29M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 4.19M sh · $131.00M · Q2 2026
- Woodline Partners LP 4.00M sh · $125.06M · Q2 2026
- TRV GP IV, LLC 6.37M sh · $120.18M · Q2 2026
- PERCEPTIVE ADVISORS LLC 3.38M sh · $105.57M · Q2 2026
- Seven Fleet Capital Management LP 3.23M sh · $95.66M · Q2 2026
More on Siren, L.L.C.
FAQ
How long has Siren, L.L.C. held TNGX?
Siren, L.L.C. has disclosed TNGX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Siren, L.L.C.'s current position in TNGX?
As of Q3 2026, Siren, L.L.C. holds 6.78M shares of TNGX (Tango Therapeutics, Inc.), valued at $169.26M, representing 4.02% of its reported portfolio and ranking #6.
Has Siren, L.L.C. been buying or selling TNGX?
In the latest 13F filing (Q3 2026), Siren, L.L.C. increased its position in TNGX. The position peaked in Q2 2026 at 6.18M shares.
Which other funds hold TNGX?
Other major institutional holders of TNGX include RTW INVESTMENTS, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 84 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.